The market is segmented based on Global AI-Powered Drug Delivery Systems Market Segmentation, By Drug Type (Small Molecule Drugs, Biologics, Gene Therapy Drugs, Protein Drugs, Others), Technology (Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP), Neural Networks, Reinforcement Learning), Component (Hardware, Software, Services), Application (Cancer Treatment, Diabetes Management, Cardiovascular Diseases, Neurological Disorders, Pain Management, Respiratory Diseases, Others), Route of Administration (Oral, Injectable, Transdermal, Inhalation, Ocular, Others), End User (Hospitals, Research Institutions, Pharmaceutical Companies, Biotech Companies, Clinics, Others) – Industry Trends and Forecast to 2032
.
The Global Ai Powered Drug Delivery Systems Market size was valued at USD 2.05 USD Billion in 2024.
The Global Ai Powered Drug Delivery Systems Market is projected to grow at a CAGR of 22.1% during the forecast period of 2025 to 2032.
The major players operating in the market include BD , Medtronic , Insulet Corporation , Novartis International AG , Johnson & Johnson ServicesInc. , F. Hoffmann-La Roche Ltd , Pfizer Inc. , AbbVie Inc. , Zynerba PharmaceuticalsInc. , Hikma Pharmaceuticals PLC , Elanco Animal Health , Cerus Corporation , Siemens Healthineers , Stryker Corporation , DexcomInc. , Huma Therapeutics , Veeva Systems Inc. , IntralytixInc. , and Viatris Inc. .
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.